Royal Bank of Canada’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-281
| Closed | -$2K | – | 7085 |
|
|
2023
Q3 | $2K | Buy |
281
+271
| +2,710% | +$1.93K | ﹤0.01% | 6333 |
|
|
2023
Q2 | $0 | Buy |
10
+2
| +25% | – | ﹤0.01% | 7210 |
|
|
2023
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 7035 |
|
|
2022
Q4 | $0 | Sell |
8
-13
| -62% | – | ﹤0.01% | 7286 |
|
|
2022
Q3 | $0 | Hold |
21
| – | – | ﹤0.01% | 7408 |
|
|
2022
Q2 | $0 | Sell |
21
-56
| -73% | – | ﹤0.01% | 7238 |
|
|
2022
Q1 | $1K | Sell |
77
-119
| -61% | -$1.55K | ﹤0.01% | 7147 |
|
|
2021
Q4 | $11K | Buy |
196
+70
| +56% | +$3.93K | ﹤0.01% | 6499 |
|
|
2021
Q3 | $12K | Buy |
126
+48
| +62% | +$4.57K | ﹤0.01% | 6384 |
|
|
2021
Q2 | $13K | Sell |
78
-7
| -8% | -$1.17K | ﹤0.01% | 6277 |
|
|
2021
Q1 | $16K | Buy |
+85
| New | +$16K | ﹤0.01% | 6067 |
|